Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Satellos Bioscience Inc. before investing.

In this article, we go over a few key elements for understanding Satellos Bioscience Inc.’s stock price such as:

• Satellos Bioscience Inc.’s current stock price and volume
• Why Satellos Bioscience Inc.’s stock price changed recently
• Upgrades and downgrades for MSLE from analysts
• MSLE’s stock price momentum as measured by its relative strength

About Satellos Bioscience Inc. (MSLE)

Before we jump into Satellos Bioscience Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Satellos Bioscience Inc., a clinical-stage drug development company, focuses on restoring natural muscle repair and regeneration in degenerative muscle diseases in Canada, the United States, and Australia. The company uses its proprietary discovery platform MyoReGenX, an automated microscopy system that recapitulates the muscle stem cell environment ex-vivo. It develops SAT-3247, an oral, small molecule drug candidate for the treatment of Duchenne muscular dystrophy disease. The company has a license agreement the with Ottawa Hospital Research Institute (OHRI); and an option agreement with the University of British Columbia. Satellos Bioscience Inc. was founded in 2018 and is headquartered in Toronto, Canada.

Want to learn more about Satellos Bioscience Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Satellos Bioscience Inc..

Satellos Bioscience Inc.’s Stock Price as of Market Close

As of November 13, 2026, 4:00 PM, CST, Satellos Bioscience Inc.’s stock price was $6.625.

Satellos Bioscience Inc. is down 3% from its previous closing price of $6.830.

During the last market session, Satellos Bioscience Inc.’s stock traded between $6.590 and $7.140. Currently, there are approximately 21.18 million shares outstanding for Satellos Bioscience Inc..

Satellos Bioscience Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Satellos Bioscience Inc. Stock Price History

Satellos Bioscience Inc.’s (MSLE) price is currently down 1.12% so far this month.

During the month of November, Satellos Bioscience Inc.’s stock price has reached a high of $7.590 and a low of $6.100.

Over the last year, Satellos Bioscience Inc. has hit prices as high as $13.395 and as low as $5.303.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Satellos Bioscience Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of November 13, 2026, there was 1 analyst who downgraded Satellos Bioscience Inc.’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate Satellos Bioscience Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Satellos Bioscience Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Satellos Bioscience Inc. (MSLE) by visiting AAII Stock Evaluator.

Relative Price Strength of Satellos Bioscience Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of November 13, 2026, Satellos Bioscience Inc. has a weighted four-quarter relative price strength of 2.98%, which translates to a Momentum Score of 65 and is considered to be Strong.

Want to learn more about how Satellos Bioscience Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Satellos Bioscience Inc. Stock Price: Bottom Line

As of November 13, 2026, Satellos Bioscience Inc.’s stock price is $6.625, which is down 3% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Satellos Bioscience Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.